Synthesis and Mechanism of p53-MDM2 Inhibitors with Heterocyclic Structures: A Focused Review

被引：0

作者：

Ji, Li-Tao ^{[1
]}

Zhang, Wenjing ^{[1
]}

Zhang, Yi ^{[1
]}

Zhao, Su ^{[1
]}

Long, Hai-Tao ^{[1
]}

Qin, Li-Qing ^{[1
]}

Tian, Jia-Cheng ^{[1
]}

Li, Hong-Zhang ^{[1
]}

Zhu, Dan-Xue ^{[1
]}

Zhou, Yan ^{[1
]}

Lu, Yi-Duo ^{[1
]}

Wang, Zhen-Chao ^{[1
,2
,3
]}

Li, Cheng-Peng ^{[1
,2
,3
]}

机构：

[1] Guizhou Univ, Coll Pharm, Guiyang 550025, Guizhou, Peoples R China

[2] Minist Educ, State Key Lab Breeding Base Green Pesticide & Agr, Key Lab Green Pesticide & Agr Bioengn, Guiyang 550025, Peoples R China

[3] Guizhou Univ, Guizhou Engn Lab Synthet Drugs, Guiyang 550025, Peoples R China

来源：

CHEMISTRYSELECT | 2023年 / 8卷 / 45期

关键词：

Small molecule; heterocyclic compounds; p53-MDM2; cancer; synthesis method; SMALL-MOLECULE INHIBITORS; PROTEIN-PROTEIN INTERACTION; STRUCTURE-BASED DESIGN; BIOLOGICAL EVALUATION; MDM2; INHIBITORS; SPIRO-OXINDOLES; CLINICAL-TRIALS; P53; PATHWAY; POTENT; DISCOVERY;

D O I：

10.1002/slct.202302240

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

P53 gene mutation is one of the important causes in tumors. p53-MDM2 (murine double minute 2) inhibitors can interrupt p53-dependent gene transcription activity, and inhibit p53-mediated apoptosis, block p53-MDM2/MDMx interaction, and significantly reduce DNA formation. In this article, we focused on the synthesis methods about nutlins and other p53 small molecule inhibitors, in order to find potential new structure for novel p53 small molecule inhibitor synthesizing. Mutation of the p53 gene is among the most important causes of tumors. Inhibitors of p53-MDM2 can impede p53-dependent gene transcription, inhibit p53-mediated apoptosis, block p53-MDM2/MDMx interaction, and significantly reduce DNA formation. In this review we discuss the synthesis of nutlins and other small-molecule p53 inhibitors, with an aim to inspire new structures and methods for the synthesis of future small-molecule p53 inhibitors.+image

引用

页数：16

共 50 条

[21] Insight on Heterocycles as p53-MDM2 Protein-Protein Interaction Inhibitors: Molecular Mechanism for p53 Activation
Basha, N. Jeelan
Mohan, R. M.
CHEMISTRYSELECT, 2024, 9 (10):
[22] Patented inhibitors of p53-Mdm2 interaction (2006-2008)
Weber, Lutz
EXPERT OPINION ON THERAPEUTIC PATENTS, 2010, 20 (02) : 179 - 191
[23] Design, Synthesis and Biological Evaluation of Sulfamide and Triazole Benzodiazepines as Novel p53-MDM2 Inhibitors
Yu, Zhiliang
Zhuang, Chunlin
Wu, Yuelin
Guo, Zizhao
Li, Jin
Dong, Guoqiang
Yao, Jianzhong
Sheng, Chunquan
Miao, Zhenyuan
Zhang, Wannian
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (09): : 15741 - 15753
[24] Relevance of the p53-MDM2 axis to aging
Wu, Danyi
Prives, Carol
CELL DEATH AND DIFFERENTIATION, 2018, 25 (01): : 169 - 179
[25] An Effective Virtual Screening Protocol To Identify Promising p53-MDM2 Inhibitors
Tortorella, Paolo
Laghezza, Antonio
Durante, Milena
Gomez-Monterrey, Isabel
Bertamino, Alessia
Campiglia, Pietro
Loiodice, Fulvio
Daniele, Simona
Martini, Claudia
Agamennone, Mariangela
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2016, 56 (06) : 1216 - 1227
[26] p53-Mdm2 - the affair that never ends
Alarcon-Vargas, D
Ronai, Z
CARCINOGENESIS, 2002, 23 (04) : 541 - 547
[27] Dynamics in the p53-Mdm2 ubiquitination pathway
Brooks, CL
Gu, W
CELL CYCLE, 2004, 3 (07) : 895 - 899
[28] The p53-MDM2 interaction in adult medulloblastomas
Giordana, MT
Schiffer, P
Boghi, A
Pradotto, L
Morra, I
Mauro, A
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (05): : 447 - 447
[29] Oscillations by the p53-Mdm2 feedback loop
Lahav, Galit
CELLULAR OSCILLATORY MECHANISMS, 2008, 641 : 28 - 38
[30] Cyclic β-Hairpin-like Peptidomimetics as p53-MDM2 Interaction Inhibitors
Jain, Priyesh
Liang, Yi
Li, Xiaolong
Badger, David
Chen, Jiandong
McLaughlin, Mark L.
BIOPOLYMERS, 2011, 96 (04) : 459 - 459

← 1 2 3 4 5 →